Conventional immunosuppressive therapy in severe Behcet ’s Uveitis: the switch rate to the biological agents

To report the switch rate of conventional immunosuppressive (CIS) therapies to the biological agents (BA) in patients with refractory Behcet ’s uveitis (BU).

Source: BMC Ophthalmology - October 5, 2018 Category: Opthalmology Authors: Hande Celiker, Haluk Kazokoglu and Haner Direskeneli Tags: Research article Source Type: research